For citations:
Kosobutskaya S.A., Ausheva D.Kh., Amirova M.A., Belaya M.V., Startseva S.A., Samokhina A.A., Vasileva Ya.A., Kochetkova S.A., Tsomaev B.P., Dzgoev G.M., Kokaeva N.T., Sidakova M.I., Kasaeva A.T. Incretin-based therapy under pricing pressure: clinico-economic perspectives and role of biosimilar glucagon-like peptide-1 receptor agonists. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.363
JATS XML
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 